Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,988 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma

NCT05846750

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tian, China

View Trial Details

Recruiting

CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma

NCT05948033

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: China Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital, China

View Trial Details

Recruiting

Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development

NCT05924347

Conditions: 22q11 Deletion Syndrome, 22q11.2 Deletion Syndrome, Abnormalities, Multiple, +19 more
Locations: UMC Utrecht Utrecht, Netherlands

View Trial Details

Recruiting

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

NCT05899621

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

NCT05846763

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Frontline of ASCT in High-risk DLBCL

NCT05831865

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

NCT05842707

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shanghai Tongji Hospital, Tongji University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

NCT05840575

Conditions: Cancer, Chemically-Induced Disorders, Chemo-brain, +37 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Recruiting

Novel MRI Techniques on Evaluation of Lymphedema

NCT05804643

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Lymphedema, +1 more
Locations: National Taiwan university hospital Taipei, Taiwan

View Trial Details

Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04920617

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Compassionate Cancer Care Medical Group Fountain Valley, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

BRCR Medical Center Inc. Hollywood, Florida, United States

BRCR Medical Center Inc. Plantation, Florida, United States

View all 50 locations

View Trial Details